Halozyme wins Dutch court injunction blocking Merck Keytruda SC in eight European markets over EP622 patent

Bitget2026/10/07 12:31

Halozyme won a Dutch court injunction barring Merck’s Keytruda SC manufacture, sale, import, or stocking across several European markets. The Hague court found infringement of Halozyme’s EP 2,797,622 patent, rejecting Merck’s invalidity challenge. Order targets Merck’s European authorization holder MSD BV, restricting use of its marketing authorization to support affiliates. Keytruda’s IV version remains available, not covered by the injunction. Halozyme is also pursuing enforcement in Germany, where it won a preliminary injunction in December 2025, plus U.S. litigation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070830PR_NEWS_USPR_____LA65803) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Goldman Sachs expects $7.5 billion in buying of gold and silver in January next year, while crude oil faces selling pressure of $7.9 billion.

金十数据•2026/11/07 03:47

Pyth October Report: ARR Jumps 18.9% as Data Expansion Accelerates

Coinpedia•2026/11/07 03:27

Elon Musk: SpaceX (SPCX.US) Q4 revenue is expected to increase by approximately 70% quarter-on-quarter, with government contract income share falling below 10%

Elon Musk stated on Friday that SpaceX (SPCX.US) will continue to reduce its dependence on U.S. government procurement contracts.

智通财经•2026/11/07 02:16

After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.

The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.

华尔街见闻•2026/11/06 23:26